Tag: Dr Robert A Wood
Biologic Showing Promise as Food Allergy Treatment in Ongoing Phase 3...
Assessment for both single agent and add-on therapy.
FDA Green Lights Phase 2 Trials of PVX108, a Novel Peptide-Driven...
Phase 2 study of candidate from Aravax will commence in the US and Australia.
Following OIT, Certain Egg Allergy Patients Likely to Consume and Tolerate...
Subjects achieving sustained unresponsiveness to egg following four years of oral immunotherapy likely to consume and tolerate eggs five years later.
Food Allergy Immunotherapy Advances Presented at AAAAI Meeting
Here's a quick recap from this morning's AAAAI press release.
